Plain-English translation of NCT07543861 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
Read our Parkinson Disease research guide โPhase 1 โ Testing in a small group (usually 20โ80 people) to find a safe dose and watch for side effects.
This is an early-stage study testing a dynamic standing desk โ a special desk that moves and shifts while you stand at it โ as a way to help people with Parkinson's disease improve their balance, posture, and movement control. The desk creates gentle, continuous adjustments that may help retrain your body's balance system. Researchers want to see if this treatment is safe and whether it helps with Parkinson's symptoms.
People with Parkinson's disease often struggle with balance and stability, which increases their risk of falls and injuries. Current treatments focus mainly on medication, so researchers are exploring whether specialized equipment like this dynamic standing desk could offer an additional way to help improve movement and reduce fall risk.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
You would visit the lab for up to 14 sessions over 6 weeks: an initial assessment visit, up to 12 four-hour sessions using the dynamic standing desk, and a final assessment visit. During the four-hour sessions, you'll stand at the desk while it makes gentle movements and adjustments. At the beginning and end of the study, researchers will perform clinical tests and measurements to see if the treatment has affected your balance, movement, and Parkinson's symptoms.
AI-generated summary from trial data ยท Aug 16, 2026 ยท Not medical advice
United States